Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Conditions: NON-ALCOHOLIC STEATOHEPATITIS Interventions: Drug: DA-1241; Drug: Sitagliptin; Drug: DA-1241 Placebo; Drug: Sitagliptin Placebo Sponsors: NeuroBo Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients
Condition:   Polycystic Ovary Syndrome Intervention:   Drug: Sitagliptin 100mg Sponsor:   Beni-Suef University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials